CELFX insider trading

Nasdaq

Cliffwater Enhanced Lending Fund — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
14
Last 90 days
1
Buys / sells
86% / 0%
Market cap

CELFX insider activity at a glance

FilingIQ has scored 14 insider transactions for CELFX since Mar 18, 2022. The most recent filing in our index is dated Mar 18, 2026.

Across the full history, 12 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CELFX insider trades is 62.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest CELFX Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for CELFX?
FilingIQ tracks 14 Form 4 insider transactions for CELFX (Cliffwater Enhanced Lending Fund), covering filings from Mar 18, 2022 onwards. 1 of those were filed in the last 90 days.
Are CELFX insiders net buyers or net sellers?
Across the full Form 4 history for CELFX, 12 transactions (86%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CELFX insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every CELFX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.